Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | L'Oréal SA | 1,095 |
| 2 | Genentech Inc | 537 |
| 3 | Symrise AG | 387 |
| 4 | Kenvue Brands LLC | 350 |
| 5 | Pfizer Inc | 336 |
| 6 | DSM IP Assets BV | 331 |
| 7 | BASF SE | 322 |
| 8 | Pfizer Corp SRL | 297 |
| 9 | Nestec SA | 277 |
| 10 | Nicoventures Trading Ltd | 274 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 37,932 |
| 2 | A61P | Therapeutic activity (drug indications) | 27,787 |
| 3 | A61Q | Cosmetics, personal care | 12,373 |
| 4 | A23L | Foods and beverages (general) | 8,837 |
| 5 | A23V | Foods, foodstuffs - indexing scheme | 6,282 |
| 6 | C07D | Heterocyclic compounds | 5,669 |
| 7 | C12N | Microorganisms, enzymes | 5,385 |
| 8 | C07K | Peptides | 3,813 |
| 9 | G01N | Investigating / analysing materials | 3,378 |
| 10 | Y02A | Climate change adaptation | 3,251 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Pharmaceutical formulations of resveratrol and methods of use thereof | 2002 | Pharmascience Inc | 200 |
| Administration of resveratrol to prevent or treat restenosis following coronary intervention | 2001 | Pharmascience Inc | 182 |
| THE USE OF RESVERATROL TO REGULATE EXPRESSION OF APOLIPOPROTEIN A1 | 2004 | RESVERLOGIX, INC. | 117 |
| Administration of resveratrol to treat inflammatory respiratory disorders | 2005 | Ip2ipo Innovations Ltd | 107 |
| Compositions based on resveratrol | 2003 | CAUDALIE | 97 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Sirtuins and Resveratrol in Medicine | 194 |
| 2 | Phytochemicals and Antioxidant Activities | 9 |
| 3 | Heme Oxygenase-1 and Carbon Monoxide | 8 |
| 4 | Curcumin's Biomedical Applications | 7 |
| 5 | Mitochondrial Function and Pathology | 7 |
| 6 | Advancements in Transdermal Drug Delivery | 5 |
| 7 | Autophagy in Disease and Therapy | 5 |
| 8 | Cancer, Hypoxia, and Metabolism | 5 |
| 9 | Oral microbiology and periodontitis research | 5 |
| 10 | Adipose Tissue and Metabolism | 4 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Dipak K. Das | University of Connecticut | 46 |
| 2 | A Bertelli | University of Milan | 30 |
| 3 | Dominique Delmas | Université de Bourgogne | 27 |
| 4 | María P. Portillo | University of the Basque Country | 24 |
| 5 | John M. Pezzuto | University of Hawaii at Hilo | 23 |
| 6 | Jing Wang | Zhejiang University | 19 |
| 7 | Joseph Wu | New York Medical College | 17 |
| 8 | Agnes M. Rimando | Agricultural Research Service | 15 |
| 9 | Beata Olas | University of Łódź | 15 |
| 10 | David Sinclair | Harvard University | 15 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Dose translation from animal to human studies revisited | 2007 | 6415 | Sirtuins and Resveratrol in Medicine |
| Resveratrol improves health and survival of mice on a high-calorie diet | 2006 | 4252 | Genetics, Aging, and Longevity in Model Organisms |
| Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α | 2006 | 4002 | Sirtuins and Resveratrol in Medicine |
| Therapeutic potential of resveratrol: the in vivo evidence | 2006 | 3924 | Sirtuins and Resveratrol in Medicine |
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | 2003 | 3780 | Genetics, Aging, and Longevity in Model Organisms |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of resveratrol?
How extensive is the patent and publication landscape for resveratrol?
Which organizations hold the most patents related to resveratrol?
What are the main research topics associated with resveratrol?
What are examples of key resveratrol patents and their applications?